These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30106227)

  • 1. Exosomal neutral sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin/ceramide.
    Lin M; Liao W; Dong M; Zhu R; Xiao J; Sun T; Chen Z; Wu B; Jin J
    FEBS J; 2018 Oct; 285(20):3835-3848. PubMed ID: 30106227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of overexpression of a neutral sphingomyelinase on CD95-induced ceramide production and apoptosis.
    Tepper AD; Ruurs P; Borst J; van Blitterswijk WJ
    Biochem Biophys Res Commun; 2001 Jan; 280(3):634-9. PubMed ID: 11162568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
    Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
    Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling.
    Yabu T; Shiba H; Shibasaki Y; Nakanishi T; Imamura S; Touhata K; Yamashita M
    Cell Death Differ; 2015 Feb; 22(2):258-73. PubMed ID: 25168245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human alkaline ceramidase 2 promotes the growth, invasion, and migration of hepatocellular carcinoma cells via sphingomyelin phosphodiesterase acid-like 3B.
    Liu B; Xiao J; Dong M; Qiu Z; Jin J
    Cancer Sci; 2020 Jul; 111(7):2259-2274. PubMed ID: 32391585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis.
    Watanabe M; Kitano T; Kondo T; Yabu T; Taguchi Y; Tashima M; Umehara H; Domae N; Uchiyama T; Okazaki T
    Cancer Res; 2004 Feb; 64(3):1000-7. PubMed ID: 14871831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma.
    Krautbauer S; Meier EM; Rein-Fischboeck L; Pohl R; Weiss TS; Sigruener A; Aslanidis C; Liebisch G; Buechler C
    Biochim Biophys Acta; 2016 Nov; 1861(11):1767-1774. PubMed ID: 27570113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of ceramide in lipid-rich microdomains (rafts): antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2.
    Goswami R; Ahmed M; Kilkus J; Han T; Dawson SA; Dawson G
    J Neurosci Res; 2005 Jul; 81(2):208-17. PubMed ID: 15929065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
    Wu BX; Clarke CJ; Hannun YA
    Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis.
    Zhang P; Liu B; Jenkins GM; Hannun YA; Obeid LM
    J Biol Chem; 1997 Apr; 272(15):9609-12. PubMed ID: 9092485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes.
    Guo BB; Bellingham SA; Hill AF
    J Biol Chem; 2015 Feb; 290(6):3455-67. PubMed ID: 25505180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.
    Shamseddine AA; Airola MV; Hannun YA
    Adv Biol Regul; 2015 Jan; 57():24-41. PubMed ID: 25465297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: influence of drug transport abnormalities.
    Côme MG; Bettaieb A; Skladanowski A; Larsen AK; Laurent G
    Int J Cancer; 1999 May; 81(4):580-7. PubMed ID: 10225448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
    Clarke CJ; Cloessner EA; Roddy PL; Hannun YA
    Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.
    Lee JT; Xu J; Lee JM; Ku G; Han X; Yang DI; Chen S; Hsu CY
    J Cell Biol; 2004 Jan; 164(1):123-31. PubMed ID: 14709545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise.
    Dobrzyń A; Górski J
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E277-85. PubMed ID: 11788358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingomyelin hydrolysis during apoptosis.
    Andrieu-Abadie N; Levade T
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):126-34. PubMed ID: 12531545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD).
    Wang G; Dinkins M; He Q; Zhu G; Poirier C; Campbell A; Mayer-Proschel M; Bieberich E
    J Biol Chem; 2012 Jun; 287(25):21384-95. PubMed ID: 22532571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.
    Holopainen JM; Subramanian M; Kinnunen PK
    Biochemistry; 1998 Dec; 37(50):17562-70. PubMed ID: 9860872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
    Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C
    Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.